Skip to main content
OpenTrials

Clinical trial condition

High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer

Explore clinical trials studying High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer trial results

Active, Not Recruiting

Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer

NCT06555796

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • University of Minnesota Medical Center Fairview Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
View Trial Details

Related conditions